227 related articles for article (PubMed ID: 26373563)
1. Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.
Hatemi G; Ozguler Y; Direskeneli H; Mahr A; Gul A; Levi V; Aydin SZ; Mumcu G; Sertel-Berk O; Stevens RM; Yazici H; Merkel PA
J Rheumatol; 2015 Dec; 42(12):2436-41. PubMed ID: 26373563
[TBL] [Abstract][Full Text] [Related]
2. Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.
Hatemi G; Meara A; Ozguler Y; Direskeneli H; Mahr A; Easley E; Gurcan M; Davis T; Gul A; Yazici Y; Zottenberg K; Esatoglu SN; Erer B; Kamali S; Yazici H; Cronholm PF; Merkel PA
J Rheumatol; 2017 Nov; 44(11):1750-1753. PubMed ID: 28365574
[TBL] [Abstract][Full Text] [Related]
3. Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making.
Toupin-April K; Barton J; Fraenkel L; Li L; Grandpierre V; Guillemin F; Rader T; Stacey D; Légaré F; Jull J; Petkovic J; Scholte-Voshaar M; Welch V; Lyddiatt A; Hofstetter C; De Wit M; March L; Meade T; Christensen R; Gaujoux-Viala C; Suarez-Almazor ME; Boonen A; Pohl C; Martin R; Tugwell PS
J Rheumatol; 2015 Dec; 42(12):2442-7. PubMed ID: 25877502
[TBL] [Abstract][Full Text] [Related]
4. Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.
Aydin SZ; Direskeneli H; Sreih A; Alibaz-Oner F; Gul A; Kamali S; Hatemi G; Kermani T; Mackie SL; Mahr A; Meara A; Milman N; Nugent H; Robson J; Tomasson G; Merkel PA
J Rheumatol; 2015 Dec; 42(12):2465-9. PubMed ID: 26077399
[TBL] [Abstract][Full Text] [Related]
5. OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research.
Beaton DE; Dyer S; Boonen A; Verstappen SM; Escorpizo R; Lacaille DV; Bosworth A; Gignac MA; Leong A; Purcaru O; Leggett S; Hofstetter C; Peterson IF; Tang K; Fautrel B; Bombardier C; Tugwell PS
J Rheumatol; 2016 Jan; 43(1):214-22. PubMed ID: 26329339
[TBL] [Abstract][Full Text] [Related]
6. Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.
Bykerk VP; Lie E; Bartlett SJ; Alten R; Boonen A; Christensen R; Furst DE; Hewlett S; Leong AL; Lyddiatt A; March L; May JE; Montie P; Orbai AM; Pohl C; Scholte Voshaar M; Woodworth T; Bingham CO; Choy EH
J Rheumatol; 2014 Apr; 41(4):799-809. PubMed ID: 24584927
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
[TBL] [Abstract][Full Text] [Related]
8. Outcome Domains and Measures in Total Joint Replacement Clinical Trials: Can We Harmonize Them? An OMERACT Collaborative Initiative.
Singh JA; Dohm M; Sprowson AP; Wall PD; Richards BL; Gossec L; Hawker GA; Riddle DL; Buchbinder R
J Rheumatol; 2015 Dec; 42(12):2496-502. PubMed ID: 25834208
[TBL] [Abstract][Full Text] [Related]
9. Core Set of Domains for Outcome Measures in Behçet's Syndrome.
Hatemi G; Meara A; Özgüler Y; Direskeneli H; Mahr A; Shea B; Cam E; Gul A; Yazici Y; Tugwell P; Yazici H; Merkel PA;
Arthritis Care Res (Hoboken); 2022 Apr; 74(4):691-699. PubMed ID: 33202101
[TBL] [Abstract][Full Text] [Related]
10. Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process.
Robson JC; Milman N; Tomasson G; Dawson J; Cronholm PF; Kellom K; Shea J; Ashdown S; Boers M; Boonen A; Casey GC; Farrar JT; Gebhart D; Krischer J; Lanier G; McAlear CA; Peck J; Sreih AG; Tugwell PS; Luqmani RA; Merkel PA
J Rheumatol; 2015 Nov; 42(11):2204-9. PubMed ID: 26329344
[TBL] [Abstract][Full Text] [Related]
11. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
[TBL] [Abstract][Full Text] [Related]
12. Outcome measures used in clinical trials for Behçet syndrome: a systematic review.
Hatemi G; Merkel PA; Hamuryudan V; Boers M; Direskeneli H; Aydin SZ; Yazici H
J Rheumatol; 2014 Mar; 41(3):599-612. PubMed ID: 24488418
[TBL] [Abstract][Full Text] [Related]
13. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.
Toupin-April K; Barton J; Fraenkel L; Li LC; Brooks P; De Wit M; Stacey D; Légaré F; Meara A; Shea B; Lyddiatt A; Hofstetter C; Gossec L; Christensen R; Scholte-Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Pohl C; Jull JE; Sivarajah S; Campbell W; Alten R; Karuranga S; Morgan E; Kaufman J; Hill S; Maxwell LJ; Welch V; Beaton D; El-Miedany Y; Tugwell PS
J Rheumatol; 2017 Oct; 44(10):1544-1550. PubMed ID: 28765239
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for the Involvement of Patient Research Partners (PRP) in OMERACT Working Groups. A Report from the OMERACT 2014 Working Group on PRP.
Cheung PP; de Wit M; Bingham CO; Kirwan JR; Leong A; March LM; Montie P; Scholte-Voshaar M; Gossec L
J Rheumatol; 2016 Jan; 43(1):187-93. PubMed ID: 25877496
[TBL] [Abstract][Full Text] [Related]
15. Current Status of Efforts on Standardizing Magnetic Resonance Imaging of Juvenile Idiopathic Arthritis: Report from the OMERACT MRI in JIA Working Group and Health-e-Child.
Nusman CM; Ording Muller LS; Hemke R; Doria AS; Avenarius D; Tzaribachev N; Malattia C; van Rossum MA; Maas M; Rosendahl K
J Rheumatol; 2016 Jan; 43(1):239-44. PubMed ID: 25979714
[TBL] [Abstract][Full Text] [Related]
16. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R
J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393
[TBL] [Abstract][Full Text] [Related]
17. Updating the OMERACT filter at OMERACT 11.
Kirwan JR; Boers M; Tugwell P
J Rheumatol; 2014 May; 41(5):975-7. PubMed ID: 24788466
[TBL] [Abstract][Full Text] [Related]
18. Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.
Idzerda L; Rader T; Tugwell P; Boers M
J Rheumatol; 2014 May; 41(5):986-93. PubMed ID: 24584917
[TBL] [Abstract][Full Text] [Related]
19. Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.
Boers M; Idzerda L; Kirwan JR; Beaton D; Escorpizo R; Boonen A; Magasi S; Sinha I; Stucki G; Tugwell P
J Rheumatol; 2014 May; 41(5):978-85. PubMed ID: 24584922
[TBL] [Abstract][Full Text] [Related]
20. Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12.
van Tuyl LH; Sadlonova M; Davis B; Flurey C; Goel N; Hewlett SE; Hill CL; Hoogland W; Kirwan JR; van Schaardenburg D; Scholte-Voshaar M; Smolen JS; Stamm T; Wells GA; Boers M
J Rheumatol; 2016 Jan; 43(1):203-7. PubMed ID: 25684772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
